Trial record 68 of 82 for: GRAZOPREVIR ANHYDROUS AND ELBASVIR
Portal-724 MEMS for Medication Adherence Patients Taking HCV Medications
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02858050|
Recruitment Status : Completed
First Posted : August 8, 2016
Results First Posted : December 11, 2018
Last Update Posted : December 11, 2018
Saint Michael's Medical Center
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Jihad Slim, MD, Saint Michael's Medical Center
|Study Design||Observational Model: Cohort; Time Perspective: Prospective|
Device: Portal-724 MEMs Cap
A limitation to our pilot study might be the small sample size and a larger study might detect a difference in adherence.